Results

Total Results: 344 records

Showing results for "liver".
Users also searched for: hepatitis c

101. Chronic-Kidney-Disease-Anemia-2011 Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_executive.pdf
     January 01, 2011 - Serum ferritin reflects storage iron—iron that is stored in liver, spleen, and bone marrow reticuloendothelial … • Hepcidin: Hepcidin is a peptide produced by the liver that regulates both iron absorption in the … QUantum Interference Device (SQUID) is a noninvasive method for the detection and quantification of liver … content,15 because of the paramagnetic properties of iron, magnetic resonance signal diminishes in liver … at week 4 in the CHr group), sudden death by unknown cause (at week 16 in the CHr group), and liver

102. Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: Final Update of a Rapid, Living Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
     December 31, 2022 - groups were comparable in terms of COVID-19 severity and baseline characteristics.22 In this study, liver … Humoral response to SARS-CoV-2 infection among liver transplant recipients. … Changes in humoral immune response after SARS‐CoV‐2 infection in liver transplant recipients compared … Decreased Long‐Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver … Liver Transplantation. 2022;28(6):1039-50. doi: https://doi.org/10.1002/lt.26389. 25.

103. Wilson Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/wilson-disease

104. Comparative Effectiveness of Hepatitis C Treatment Adherence Interventions | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/hepatitis-c-treatment-adherence/research-protocol

105. Developing and Piloting a Tool To Create Dot Plots To Summarize Pooled Data for Multiple Outcomes in Systematic Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dot-plots-methods.pdf
     October 01, 2021 - composite cardiovascular outcomes, withdrawal due to adverse events, cancer, diabetes, myalgia, and liver … 29536 896 29547 1.05 0.91 1.20 0.52 High Myalgia 8 1679 18223 1545 17384 0.96 0.79 1.16 0.42 High Liver

106. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay/research

107. Gaucher Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/gaucher-disease

108. Developing and Piloting a Tool To Create Dot Plots To Summarize Pooled Data for Multiple Outcomes in Systematic Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/dot-plots-methods.pdf
     October 01, 2021 - composite cardiovascular outcomes, withdrawal due to adverse events, cancer, diabetes, myalgia, and liver … 29536 896 29547 1.05 0.91 1.20 0.52 High Myalgia 8 1679 18223 1545 17384 0.96 0.79 1.16 0.42 High Liver

109. Implementing Evidence-Based Screening and Counseling for Unhealthy Alcohol-Use With Epic-Based Electronic Health Record Tools: A Guide for Clinics and Health Systems Developed as Part of a Pilot Dissemination Project (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/implementation-package-unhealthy-alcohol-use-final.pdf
     September 01, 2018 - of many adverse health outcomes, including cancers (oral cavity, esophagus, larynx, colon, rectum, liver … , and breast), gastrointestinal problems (e.g., liver cirrhosis, pancreatitis, ulcers), cardiovascular … Specifically, it increases the risk for several types of cancer, include cancer of the head and neck, colon, liver … It also increases the risk of stroke, heart attack, high blood pressure, liver cirrhosis, depression … Also, I would not want to have liver failure.

110. Alcohol-Misuse Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_executive.pdf
     April 28, 2010 - The damage may be either physical (e.g., liver damage from chronic drinking) or mental (e.g., depressive … Insufficient Health Alcohol-related liver problems Evidence was insufficient to draw conclusions. … Insufficient Health Alcohol-related liver problems Evidence was insufficient to draw conclusions. … Low Alcohol-related liver problems Evidence was insufficient to draw conclusions. … about the effectiveness of behavioral interventions compared with controls (e.g., alcohol-related liver

111. Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
     January 01, 2013 - Interference Devices (SQUIDs) are an alternative non-invasive means for detecting and quantifying liver … iron content, via the paramagnetic properties of iron (magnetic resonance diminishes in the liver as … Hepcidin is a peptide produced by the liver that regulates both iron absorption in the intestine as … They operate by exploiting the paramagnetic properties of iron: magnetic resonance diminishes in the liver … Background Iron overload increases the risk for liver disease (cirrhosis, cancer), heart attack or heart

112. Treatment of Hepatitis C Virus Infection in Adults: Future Research Needs | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/hepatitis-c-treatment-future/research

113. Gallstones | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/gallstones

114. Impact of Contacting Study Authors on Systematic Review Conclusions: Diagnostic Tests for Hepatic Fibrosis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/hepatic-fibrosis/white-paper

115. Ch-7-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch-7-user-guide-to-ocer_130129.pdf
     March 29, 2012 - Consider a highly simplified hypothetical study to compare rates of acute liver failure between new … Unmeasured alcohol use (U2) influences impotence and erectile dysfunction treatment (F 0 ) and acute liver … In this example there is no effect of antihypertensive treatment on liver disease, but antihypertensive … treatment and liver disease would be associated when adjusting for medical treatment of erectile dysfunction

116. high-cholesterol-medicines-update-protocol-130516 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
     December 31, 2013 - These agents reduce the production of cholesterol in the liver by binding with the enzyme responsible … statin treatment alone.20 There may also be fewer statin-related side effects, such as myalgias and liver … tiab] OR rapeseed [tiab] OR canola [tiab] OR soybean [tiab] OR walnut [tiab]) AND Oil[tiab]) OR cod liver … oil[MH] OR “cod liver oil”[tiab] OR salmon[MH] OR salmon[tiab]OR mackerel[MH] mackerel[tiab] or tuna

117. Treatment for Hepatitis C Virus Infection in Adults | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/hepatitis-c/research

118. Screening for Hepatitis C Virus Infection in Adults | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/hepatitis-c-screening/research

119. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - drug should be avoided in patients with a history of bile duct obstruction, pancreatitis, severe liver … and children who are at least 12 years old and for treating hepatic encephalopathy in adults with liver … and children who are at least 12 years old and for treating hepatic encephalopathy in adults with liver

120. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Long-term PN can, however, lead to serious side effects, such as liver damage, the risk of which increases … patient per year.3 Long-term parenteral nutrition (PN) can lead to serious side effects, such as liver … however most patients should look forward to less reliance on PN which in the long run will help reduce liver